Bid Publish Date
20-Mar-2025, 5:52 pm
Bid End Date
10-Apr-2025, 6:00 pm
Location
Progress
Indian Council Of Medical Research (icmr) has released a public tender for Nucleic Acid Sequencing and Genotyping Service - Meta Genome; Stool; Human / Animal Tissue; To be collected by the service provider from the buyer; Pac Bio; 95% and above; 50x; High throughput; Secondary analysis; Physical media, Cloud storage; 30 da. . in BHOPAL, MADHYA PRADESH. Quantity: 96. Submission Deadline: 10-04-2025 18: 00: 00. Download documents and apply online.
| S.No | Seller | Date | Status |
|---|---|---|---|
| 1 | EUROFINS GENOMICS INDIA PRIVATE LIMITED Under PMA | 10-04-2025 17:35:30 | |
| 2 | NUCLEOME INFORMATICS PRIVATE LIMITED Under PMA | 10-04-2025 13:46:49 |
| Rank | Seller | Price | Item |
|---|---|---|---|
| L1 | NUCLEOME INFORMATICS PRIVATE LIMITED( MSE Social Category:General ) Under PMA | Item Categories : Nucleic Acid Sequencing and Genotyping Service - Meta Genome; Stool; Human / Animal Tissue; To be c |
Please sign in or create an account to view contract details and download result documents.
Quantity
96
Bid Type
Two Packet Bid
Bid Validity
155 (Days)
Bid Type
Service
Evaluation
Total value wise evaluation
Tech Clarification Time
2 Days
Startup Exemption (Experience)
Yes
Min. Avg. Annual Turnover
2
Experience Required
3 Year (s)
Arbitration Clause
No
Mediation Clause
No
Tender Category
Service
Bid To RA
No
Bid To RA Enabled
No
Item Category
Nucleic Acid Sequencing and Genotyping Service - Meta Genome; Stool; Human / Animal Tissue; To be collected by the service provider from the buyer; Pac Bio; 95% and above; 50x; High throughput; Secondary analysis; Physical media, Cloud storage; 30 da..
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
SCOPE_OF_WORK
GEM_GENERAL_TERMS_AND_CONDITIONS
Experience Criteria
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
Additional Doc 1 (Requested in ATC)
Additional Doc 2 (Requested in ATC)
Additional Doc 3 (Requested in ATC)
Additional Doc 4 (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Key insights about MADHYA PRADESH tender market
The eligibility requirements include being a registered entity capable of delivering nucleic acid sequencing and genotyping services. Applicants must provide evidence of relevant experience in handling metagenomic samples and assure compliance with established health and research standards. Documentation supporting technical capability and business integrity is essential.
Bidders need to submit several certifications relevant to their operations. These include valid business registration certificates, quality management system certifications such as ISO, and any other certificates that demonstrate compliance with health regulations or quality standards pertinent to nucleic acid sequencing technologies.
The registration process involves submitting an online application via the specified platform along with required documents and certificates. Applicants must ensure all information is accurate, as any discrepancies may affect eligibility. It is advisable to check for specific submission guidelines prior to registration.
The technical specifications require the use of Pac Bio sequencing technology with accuracy levels of 95% or better. Quality standards demand adherence to national health protocols throughout sequential operations from sample analysis to data handling. Detailed compliance with these specifications is mandatory for successful bids.
The Earnest Money Deposit (EMD) is a prerequisite for participating in the tender and needs to be submitted along with the bid proposal. The amount specified typically aims to ensure commitment from bidders. Eligibility for exemption or adjustments based on MSE status must also be referenced.
These comprehensive FAQs aim to address potential concerns and provide clarity regarding the Nucleic Acid Sequencing and Genotyping Service tender, ensuring all interested parties have access to necessary information.